Background
==========

Cerebrospinal fluid (CSF) dynamics are thought to be altered in many pathological conditions including hydrocephalus \[[@B1],[@B2]\], idiopathic intracranial hypertension \[[@B3],[@B4]\], intracerebral haemorrhage \[[@B5]\], subarachnoid haemorrhage \[[@B6],[@B7]\], large hemispheric stroke \[[@B8],[@B9]\], traumatic brain injury \[[@B10]\], and in the aging brain \[[@B11],[@B12]\]. However, relatively little is known about the exact mechanisms of changes in CSF dynamics and drainage in these conditions due to difficulties in quantification.

The role and location of CSF drainage has been studied in both animals and humans. Traditional interpretation has been that most CSF drains into the venous sinuses via arachnoid granulations \[[@B13]-[@B15]\]. The primary site of CSF reabsorption, however, has become a contentious issue over the last decade. The importance of the olfactory perineural pathways and the cervical lymphatics \[[@B16]-[@B19]\] in reabsorbing CSF has been studied in several species, including humans. Postmortem lymphatic vascular casting \[[@B20]-[@B22]\] and radioactive albumin clearance methods \[[@B17],[@B23]-[@B25]\] have demonstrated the major contribution of these pathways in CSF drainage. Furthermore, physiological studies by Johnston's group, suggested that the arachnoid granulations may only come into play when intracranial pressure is elevated and that lymphatic drainage routes may play a major role \[[@B26],[@B27]\], especially in neonates where arachnoid granulations are sparse \[[@B28]\]. Both human and animal studies indicate that the spinal route, either via spinal arachnoid granulations or via lymphatics around spinal nerve root dural sheaths may also be important \[[@B29]-[@B35]\]. These lymphatic routes may have important immunological significance \[[@B19]\].

To investigate CSF dynamics and drainage within the entire rat brain we developed a novel contrast-enhanced computed tomography (CT) technique to image the rat CSF system in three-dimensions. One unique feature of this technique is that the dynamic nature of CSF drainage can be observed *in vivo*. We chose to compare young and aged spontaneously hypertensive rats (SHR) because their cerebral ventricular volume is thought to increase with age \[[@B36],[@B37]\], which, in addition to the hypertension, may affect CSF dynamics. In addition, this effect may also influence physiological variables such as intracranial pressure, for example, elevated ICP is seen in some hydrocephalus patients \[[@B1],[@B2]\]. Using our novel contrast-enhanced CT method, we hypothesized that the aged SHRs would have altered CSF dynamics and drainage and a higher baseline ICP when compared to the young SHRs.

Methods
=======

All animal experiments were conducted in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes and were approved by The University of Newcastle Animal Care and Ethics Committee. Experiments were performed on two cohorts of male spontaneously hypertensive rats (SHR) (Animal Resources Centre, Western Australia). One group weighed 200-360 g, aged 2--5 months (n = 5); the other group weighed 360-400 g, aged 16 months (n = 5). Due to ethical constraints, we calculated the sample size required to detect a difference in baseline ICP between two different rat strains (Wistar and Long Evans; data previously published \[[@B38]\]). Using an alpha of 0.05 and Power of 0.80, a sample size of 5 animals per group was required to detect a 4.2 mmHg difference between baseline ICP in the two rat strains.

Surgery and physiological monitoring
------------------------------------

Animals were anaesthetised with isoflurane (5% induction, 2% maintenance) in 50:50%, N~2~:O~2~ via a facemask. It has previously been reported in dogs that isoflurane causes no significant change in the rate of CSF production \[[@B39]\]. Respiratory rate was regularly monitored and core temperature was maintained at 37°C via a thermocouple rectal probe and warming plate for the duration of surgical anaesthesia. Incision sites were shaved, cleaned and injected subcutaneously with 2 mg/kg 0.05% Bupivacaine (Pfizer, Australia). To measure arterial blood pressure under anaesthetic, a fibreoptic microcatheter (SAMBA Sensors, Sweden) was briefly inserted into the saphenous branch of the femoral artery, and a steady state baseline arterial blood pressure trace was recorded.

Intracranial pressure (ICP) was recorded prior to scanning using a SAMBA microcatheter as previously described \[[@B40]\] with minor changes. Briefly, animals were placed in the ear bars of a custom-built CT-compatible stereotaxic frame. Hollow poly-ether-ether-ketone (PEEK) screws (Solid Spot LLC, Santa Clara, CA, USA) of 2 mm in diameter × 5 mm in length were inserted bilaterally 0.3 mm caudal and 1.5 mm lateral to Bregma. The ICP probe was inserted into the right screw and an airtight seal made by surrounding both screws in a biocompatiable caulking material (Silagum, DMG Dental, Hamburg, Germany). The probe was removed prior to scanning.

Computed tomography (CT) imaging
--------------------------------

Following baseline arterial pressure and ICP measurement, animals remained on the same base plate and stereotaxic frame, which was positioned on the CT scanner table. All imaging was performed using a 64-slice clinical CT scanner (Siemens, Erlangen, Germany) \[[@B41],[@B42]\]. The CSF imaging protocol was developed specifically for the current study. Each CT-CSF imaging sequence used 0.6 mm slice thickness with coronal plane image acquisition, and a total of 90 slices captured from the rat nose to the cervical vertebrae (C2). Two 1 ml syringes and two PE-10 intraventricular catheters were then preloaded with a 1:4 dilution of Ultravist 300 mg/mL (Bayer HealthCare Pharmaceuticals Inc.) in 0.9% saline. This dilution was chosen to reduce the viscosity and make it closer to that of CSF. Care was taken to ensure that no air bubbles were present within the catheters. The catheter tips were inserted 3.5 mm below the skull into each lateral ventricle via the bilateral screws used for ICP monitoring, and a head CT scan performed (baseline scan) to ensure that catheter tips were positioned within each lateral ventricle. Using an automated syringe driver (Harvard Apparatus, Pump 11 Elite, MA, USA), contrast was injected into each ventricle at 2 μL/min for 10 minutes, with a CT scan performed every minute from the start of infusion. The infusion rate of 2 μL/min was chosen to reduce the possibility of the infusion affecting the CSF production (rodent CSF production rate previously reported as 2.66-2.84 μL/min \[[@B43]\]). Following the cessation of infusion, serial CT scans were performed every 5 minutes for 60 minutes (Figure [1](#F1){ref-type="fig"}, an additional movie file shows this in more detail \[see Additional file [1](#S1){ref-type="supplementary-material"}\]).

![**Calculating cerebrospinal fluid flow through the cerebral aqueduct of the rat.** Radio-opaque contrast (20 μl) was simultaneously injected into each lateral ventricle at 2 μl/min for 10 min while plain CT images (0.6 mm slice thickness) were taken over 60 minutes. A small region-of-interest (ROI) (yellow box, arrow) was positioned within the centre of the aqueduct and the decay rate used to generate flow maps. An additional movie file shows this in more detail \[see Additional file [1](#S1){ref-type="supplementary-material"}\].](2045-8118-11-12-1){#F1}

Processing CT images
--------------------

For each animal, serial CT images were loaded into MiStar software (Apollo Medical Imaging Technology Pty Ltd, Melbourne, Australia). Motion correction was performed, and the resulting images were subtracted from the baseline non-contrast image.

### 3D reconstruction of CT images: rat CSF system

A representative 3D reconstruction of the rat CSF system was created by generating a Maximum Intensity Projection (MIP).The MIP was loaded into the MiStar fusion 3D render module. Thresholds were applied to the 3D render to highlight the CSF system.

### Visual inspection of contrast time-course throughout CSF system

The time taken for injected contrast to reach specific anatomical landmarks within the CSF system was quantified in each animal. The anatomical landmarks included the cerebral aqueduct, 3rd ventricle, 4th ventricle, spinal canal, basal cisterns and cribriform plate. The contrast window range was set to 0--250 Hounsfield Units (HU) for each animal sequence to prevent the false detection of signal noise at each image time-point. The time taken for the contrast to reach each landmark was calculated by analysing each sequential image.

### CSF flow rate calculations

Contrast-enhanced CT images were processed using the MiStar software decay module specifically written for rat imaging. CSF flow rate measured at the cerebral aqueduct was used to estimate CSF production. Flow rates were also calculated elsewhere within the CSF system. A small region-of-interest (ROI) with 6 voxels was positioned within the centre of the aqueduct on the 10 minute time-point scan (post-infusion). The total change in Hounsfield Units for voxels within the ROI was plotted over time, and an exponential decay curve was fitted to the first five decay data points. The exponential decay rate constant is directly proportional to flow within the ROI. This principle was applied to each voxel to generate the Decay Rate Map, measured in ml/min/100 L (which was then converted to μl/min/100 ml). The ROI was then co-registered with the Decay Rate Map to obtain the flow value. Flow was converted into μl/min by multiplication with volume (slice thickness × area of ROI). The process was repeated (with the same fixed ROI) at the 3rd ventricle and 4th ventricle of each animal.

### Brain and intracranial CSF volume calculation

Twenty five 0.6 mm coronal CT slices were analysed slice-by-slice to calculate brain and CSF volume. On each slice, a threshold of 100 HU was set and ROI software tools were used to define the area of total brain tissue (using baseline scans) or contrast-enhanced CSF within the cranium. On each slice, the volume was calculated as slice thickness × area of ROI. The combined sum of the ROI volumes was calculated.

Statistics
----------

Statistical tests were performed using GraphPad Prism Version 6 for Windows (GraphPad Software, USA). Two-tailed Student's t-test was used to compare differences in CSF production rate, and CSF volumes between young and aged groups. Significance was accepted at the *p* \< 0.05 level. T-tests are also reported for physiological variables for illustrative purposes, with p-values uncorrected for use of multiple comparisons. Unless otherwise stated, data is expressed as mean ± standard deviation (±SD).

Results
=======

Physiological variables
-----------------------

Arterial blood pressure (systolic/diastolic) was measured in 3 young animals and 5 aged animals. Mean arterial blood pressure was lower in the young versus the aged animals (94 ± 32 mmHg vs. 160 ± 22 mmHg, *p* = 0.01). Intracranial pressure (ICP) was measured in all animals and traces revealed consistent pulse and respiratory waveforms. A significantly higher ICP was found in aged rats, 11.52 ± 2.36 mmHg, versus 7.04 ± 2.89 mmHg in the younger animals, *p* = 0.03. Cerebral perfusion pressure (mean arterial blood pressure - intracranial pressure) was significantly lower in the young versus the aged animals (86 ± 32 mmHg vs. 148 ± 20 mmHg, *p* = 0.02).

Cerebrospinal fluid drainage pathways and time course
-----------------------------------------------------

CSF was observed to drain into the spinal canal (subarachnoid space) and via the olfactory pathway (through the cribriform plate), the optic nerves, and the cervical lymph nodes in all animals (Figure [2](#F2){ref-type="fig"}, an additional movie file shows this in more detail \[see Additional file [2](#S2){ref-type="supplementary-material"}\]). Contrast-enhanced CSF was observed at the cerebral aqueduct 3.2 ± 0.8 minutes post-injection in both cohorts. It was first observed to enter the 3rd ventricle 1.8 ± 0.4 minutes and 1.6 ± 0.5 minutes post-injection in the young and aged respectively, the 4th ventricle at 4.4 ± 2.2 minutes and 3.8 ± 0.8 minutes post-injection, the spinal canal at 11.5 ± 9.1 minutes and 7.2 ± 0.8 minutes post-injection, and the basal cisterns at 18.5 ± 6.8 minutes and 14.0 ± 4.2 minutes post-injection in the young and the aged respectively (Figure [3](#F3){ref-type="fig"}). Contrast could be observed leaving the cranial vault at the cribriform plate 23.8 ± 6.3 minutes post-injection in the young and 21 ± 8.2 minutes in the aged (Figure [3](#F3){ref-type="fig"}). No contrast-enhanced CSF was observed at the sagittal sinus \[Additional file [1](#S1){ref-type="supplementary-material"}\].

![**Cerebrospinal fluid (CSF) system in a rat imaged with contrast-enhanced computed tomography (CT).** Images show a 3D render reconstruction of CT images after 20 μL of radio-opaque contrast was injected into each lateral ventricle via cannulae guided through hollow screws inserted into the skull. Anatomical landmarks of the CSF system in the rat are based on a stereotaxic rat atlas \[[@B61]\]. Basal cisterns are not depicted in the rat atlas, but their location at the base of the brain is indicated by presence of contrast enhanced CSF in this location. An additional movie file shows this in more detail \[see Additional file [2](#S2){ref-type="supplementary-material"}\].](2045-8118-11-12-2){#F2}

![**Time taken for contrast-enhanced cerebrospinal fluid to reach major anatomical landmarks within the rat CSF system.** Young (2--5 months); Aged (16 months). Mean ± SD.](2045-8118-11-12-3){#F3}

Cerebrospinal fluid production and flow rates and total intracranial CSF volume
-------------------------------------------------------------------------------

CSF flow was able to be quantified at multiple sites within the ventricular system, but flow quantification in the extraventricular locations was not possible due to respiratory motion artifact (spinal canal) and contrast dilution, resulting in reduced signal-to-noise ratio and partial volume averaging error caused by the extensive surface area of each drainage route. CSF production rates, as measured by CSF flow rate at the cerebral aqueduct, were 3.14 ± 2.1 μL/min and 2.79 ± 0.57 μL/min in the young and the aged, respectively. CSF flow rates were 3.74 ± 1.93 μL/min and 3.19 ± 0.70 μL/min at the 3rd ventricle and 2.89 ± 0.21 μL/min and 2.70 ± 1.29 μL/min at the 4th ventricle (Figure [4](#F4){ref-type="fig"}A- 4C). The total intracranial CSF volume was 204 ± 97 μL in the young and 275 ± 35 μL in the aged cohort (Figure [4](#F4){ref-type="fig"}D). None of these values differed significantly between the young vs. aged cohorts.

![**Cerebrospinal fluid (CSF) dynamics in the rat. (A)** Flow rate through the cerebral aqueduct; **(B)** Flow rate through the 3rd ventricle; **(C)** Flow rate through the 4th ventricle; **(D)** Total intracranial CSF volume, in young (2--5 months) versus aged (16 months) spontaneously hypertensive rats. Data presented as individual data points with mean ± SD.](2045-8118-11-12-4){#F4}

Brain volume
------------

Brain volume was 2157 ± 314 mm^3^ and 2366 ± 233 mm^3^ in the young and aged rats, respectively (Figure [5](#F5){ref-type="fig"}). CSF volumes (and as percentage of brain volume) were 204 ± 97 μL (8.8 ± 4.3%) in the young and 275 ± 35 μL (10.8 ± 1.9%) in the aged animals. These values were not significantly different.

![**Total brain volume calculated from baseline non-contrast images.** Young (2--5 months); Aged (16 months). Mean ± SD.](2045-8118-11-12-5){#F5}

Discussion
==========

This study used young and aged SHRs to demonstrate a new technique for the measurement of CSF flow, volume and drainage *in vivo*. The results of this study suggest that sagittal sinus arachnoid granulations are not the primary route of CSF drainage and that CSF is primarily absorbed via the spinal and olfactory routes. The time taken for contrast-enhanced CSF to reach each drainage route did not differ between the young and aged animals. Our novel CT method also allowed for measurement of CSF flow and volume and found that there was little difference between young and aged animals, despite a higher ICP in the aged animals. This method provides an alternative avenue for the investigation of the pathophysiological perturbations occurring in disorders of CSF regulation and abnormal intracranial pressure.

There is increasing recognition of the importance of altered CSF and brain interstitial fluid dynamics with age, not only in conditions such as normal pressure hydrocephalus but also in dementias such as Alzheimer's disease \[[@B44],[@B45]\]. Despite this, most CSF-related research occurs in young animals. In the current study we investigated CSF dynamics in an aged population of SHRs, since this strain is known to develop hypertension, ventriculomegaly and cerebral volume loss with age \[[@B36],[@B37]\]. We found little difference in the absolute CSF flow rates or total brain volume between young (2--5 months) and aged (16 months) rats. These data are similar to findings in a previous study of normotensive rats (without ventriculomegaly) aged from 3--30 months. Chiu et al. found that peak CSF production occurs at 10 months before steadily decreasing over time to almost baseline values \[[@B43]\]. Furthermore, the values they reported in 12--20 month rats ranged from 2.66-2.84 μL/min, which were comparable to our reported values in 16 month aged rats and to previously reported values in 3--4 months old rats in other studies \[[@B46],[@B47]\]. It is also interesting to note that the CSF flow rates, when measured at different anatomical locations within the CSF ventricular system, did not vary greatly. The lack of a significant difference in *in vivo* CSF volumes between young and aged SHRs is inconsistent with previous *in vitro* studies, and most likely due to a lack of statistical power to detect a difference in this variable. This was contributed to by small animal numbers and in particular by the significant between-animal variability in the younger cohort. The point estimate of a 26% difference is in keeping with previous published data \[[@B36],[@B37]\]. Additionally, it may be that changes would be more apparent in 'elderly' (≈2 years) animals, than in at 16 months of age. This age was chosen to avoid the tumours and mortality that increase beyond 18 months in this strain. Our data also demonstrated a significantly higher intracranial pressure (ICP) and cerebral perfusion pressure (CPP) in the aged rats when compared to the young. This is consistent with findings in humans \[[@B48],[@B49]\] and in other rat strains \[[@B50]\]. Additionally, the greater variability in CPP in the young animals may have contributed to the greater variance in CSF data, i.e. there was a greater percentage of variance (relative to the mean) in mean arterial pressure, and in ICP, in the young vs. aged. It is plausible that greater variance in CPP resulted in greater variance in CSF flow and drainage parameters, as changes in CPP may affect CSF production and drainage.

Although the ICP was higher in aged animals, we could not see any contrast adjacent to or filling the sagittal sinus to indicate drainage of the CSF via arachnoid granulations, even at the later time points. There was, however, clear evidence of passage of contrast into the spinal canal, olfactory cavity, along the ophthalmic nerves and into cervical lymph nodes. Our findings support recent studies that the primary route of CSF drainage in most mammalian species is via perineural sheaths. In anatomical studies using a coloured tracer and anatomical dissection, CSF drainage into nasal lymphatics via the olfactory nerves and cribriform plate has been demonstrated in sheep, pigs, rabbits, rats, mice and monkeys \[[@B16],[@B17],[@B20]-[@B25]\]. Additionally presence of this route has been shown in human cadavers \[[@B20]\]. Many studies have also demonstrated spinal lymphatic CSF drainage using tracers in several mammalian species including humans \[[@B22],[@B23],[@B26],[@B35],[@B51]\]. It was calculated that the rate of spinal CSF absorption was between 38--76% of CSF production in healthy individuals (higher during activity) \[[@B35]\]. At least in the sheep, the venous sinus arachnoid granulation pathway of CSF absorption appears to be a secondary pathway only recruited at high intracranial pressures, for example after a neurological injury \[[@B17],[@B28]\].

The calculation of CSF volume is technically challenging and many techniques have been tried, with varying success. Values obtained in this study correspond well to some published data in rats using quite different techniques, including volumes of 233--240 μL in young SHRs using the ventriculo-cisternal dilution method \[[@B46],[@B47]\] and volumes from 275--441 μL in Fischer 344/BN rats using magnetic resonance imaging \[[@B43]\]. However, some published studies report much higher volumes. Lai et al. (1983) reported a mean CSF volume of 580 μL in rats using the formula 'CSF volume = CSF formation rate/CSF turnover rate' \[[@B52]\]. They assumed that the CSF turnover rate was constant amongst species \[[@B53]\], and used the human CSF turnover rate of 0.38% per minute (obtained using ventriculo-lumbar perfusion method from 12 children with subacute sclerosing panencephalitis and pontine glioma) \[[@B54]\], to calculate CSF volume. We are not sure that this assumption is well justified. However, despite these potential limitations, the rat CSF volume and turnover rate from that paper appear to have become the accepted values in reviews of the field, perhaps due to the paucity of other available data \[[@B55]-[@B57]\].

Our novel CT method provides several possible advantages, and some limitations, when compared with other techniques such as the ventriculo-cisternal dilution and post-mortem dye-tracer methods. First among these is that it does not require an intracisternal draining catheter, with potential resultant effects on ICP and possibly on CSF production, if homeostatic mechanisms are evoked. Secondly, the ability to image the entire CSF system simultaneously and sequentially gives a more complete understanding of the dynamics of CSF flow and drainage. We were able to monitor the major physiological parameters thought to influence CSF production rate, that is, ICP \[[@B58]\], blood pressure \[[@B59]\], and temperature \[[@B60]\]. Additionally, flow rates, whole brain volume, and CSF volume calculations were obtained from the same study. Some unavoidable limitations also exist with the CT method, and particular points of the analysis require great care. In particular, partial volume averaging effects are a known potential problem when measuring values from a very small structure such as the cerebral aqueduct. Great care must be taken to identify the midpoint of the region of contrast enhancement for placement of a small region-of-interest. An additional limitation is that although we could observe and quantify the time taken for contrast-enhanced CSF to reach the drainage pathways *in vivo*, we have been unable to reliably quantify the volume of CSF draining via these routes.

Conclusions
===========

We have provided *in vivo* data using CT imaging of CSF distribution over time, which indicates that the primary route of CSF drainage in young and aged rats is via the spinal and olfactory lymphatics, and that drainage into the sagittal sinus arachnoid granulations plays at most a minor role. The CT technique we developed provides an alternative to ventriculo-cisternal dilution methods for measurement of CSF flow through the cerebral aqueduct, the widely accepted surrogate measure for CSF production. It avoids the need to puncture the cisterna magna and permits visualisation and timing of CSF distribution and drainage, quantification of CSF flow elsewhere within the ventricular system and measurement of total brain and intracranial CSF volumes. Interestingly, this study of young and aged SHRs suggest that CSF production rates and volumes are quite similar, and do not change dramatically with age. The information gathered using our novel contrast-enhanced CT method may provide much needed insight into the CSF dynamics and drainage involved in many neurological diseases.
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###### Additional file 1

**Contrast-enhanced cerebrospinal fluid flow through the cranium over 60 minutes.** Radio-opaque contrast (20 μl) was simultaneously injected into each lateral ventricle at 2 μl/min for 10 min while plain CT images (0.6 mm slice thickness) were taken over 60 minutes. File format: mov.
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Click here for file

###### Additional file 2

**3D render reconstruction of cerebrospinal fluid system of the rat.** The computed tomography images of one rat were loaded in MiStar software and subtracted from the baseline non-contrast image. A Maximum Instensity Projection was generation and loaded into the MiStar fusion 3D render module. File format: mov.

###### 
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